FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916036130> ?p ?o ?g. }

• W2916036130 endingPage "320" @default.
• W2916036130 startingPage "315" @default.
• W2916036130 abstract "Inverted papillomas represent one of the most common benign neoplasic lesions located in the sinonasal tract. Owing to the local erosive behavior, tendency to recur and the potential for malignant transformation, surgical management of inverted papillomas is often challenging. This study aimed to analyze the surgical outcomes of patients with inverted papillomas, according to the Krouse staging and the different surgical approaches. Retrospective study of patients diagnosed with sinonasal inverted papillomas who underwent surgical treatment between 2000 and 2016 at a tertiary referral hospital. Cases with follow-up less than 12 months were excluded. The rate and the time of recurrence were the main outcomes. Values of p < 0.05 were considered statistically significant. Thirty-six cases with mean age of 60 years, predominantly male (72%), were included. The follow-up period ranged from 1 to 16 years, with an average of 4.5 years. Krouse T1 Stage corresponded to 11.1%; T2 occurred in 50% of cases; while T3 and T4 Stages accounted for 30.6% and 8.3% of patients, respectively. Most cases were approached by an endoscopic technique alone (83.3%), with a recurrence rate of 13.3%. Patients treated via a combined or open approach revealed a recurrence of 16.7%. No differences in the recurrence rate were reported when comparing endoscopic surgery with the open or combined techniques. Krouse Stage T3 had a significant association with inverted papillomas recurrence (p = 0.023). All inverted papilloma relapses occurred up to 2 years post-operatively. One case of malignant transformation was recorded (2.7%). Endoscopic surgery did not increase the recurrence rates and can be a safe and efficient alternative to open or combined techniques. The recurrence of inverted papillomas seem to be related to the persistence of the disease and tend to occur early after primary surgery. Krouse T3 Stages may be associated with a higher recurrence of inverted papillomas. Os papilomas invertidos são uma das lesões neoplásicas benignas mais comuns no trato nasossinusal. Devido ao seu comportamento localmente agressivo, tendência para recidivar e potencial de malignização, o tratamento cirúrgico dos papilomas invertidos constitui frequentemente um desafio. Analisar os resultados cirúrgicos dos papilomas invertidos segundo o estadiamento de Krouse, bem como avaliar as diferentes abordagens cirúrgicas. Estudo retrospectivo de pacientes com diagnóstico de papiloma invertido nasossinusal submetidos a tratamento cirúrgico entre 2000 e 2016 em hospital terciário. Casos com acompanhamento inferior a 12 meses foram excluídos. A taxa e o tempo de recidiva foram os principais resultados analisados desfechos avaliados. Valores p 0,05 foram considerados estatisticamente significativos. Foram incluídos 36 casos, com média de idade de 60 anos, predominantemente do sexo masculino (72%). O período de acompanhamento variou de 1 a 16 anos, em uma média de 4,5 anos. Relativamente ao estadiamento, 11,1% dos pacientes foram classificados como estadio Krouse T1, 50% como T2, 30,6% como T3 e 8,3% como T4. A maioria dos casos foi tratada exclusivamente por cirurgia endoscópica (83,3%), com taxa de recidiva de 13,3%. Pacientes tratados com uma técnica combinada ou aberta apresentaram recidiva de 16,7%. Não foram observadas diferenças quanto à taxa de recidiva entre os casos abordados por via endoscópica e os casos tratados com técnica aberta ou combinada. Verificou-se uma associação significativa entre o estadio T3 de Krouse e recidiva de papilomas invertidos (p = 0,023). Todas as recidivas de papilomas invertidos foram observadas até dois anos após a cirurgia. Um caso de transformação maligna foi registrado (2,7%). A cirurgia endoscópica não aumentou as taxas de recidiva e pode ser uma alternativa segura e eficiente às técnicas abertas ou combinadas. Os casos de recidiva do papiloma invertido parecem estar relacionados com a persistência da doença e tendem a ocorrer precocemente após a cirurgia primária. Os estadios T3 de Krouse podem estar associados a uma maior recidiva." @default.
• W2916036130 created "2019-03-02" @default.
• W2916036130 creator A5037578201 @default.
• W2916036130 creator A5052413205 @default.
• W2916036130 creator A5060376541 @default.
• W2916036130 creator A5065042948 @default.
• W2916036130 creator A5081858972 @default.
• W2916036130 creator A5091064000 @default.
• W2916036130 date "2020-05-01" @default.
• W2916036130 modified "2023-10-15" @default.
• W2916036130 title "Surgical outcomes of sinonasal inverted papilloma: a 17 year review" @default.
• W2916036130 cites W1970499778 @default.
• W2916036130 cites W1972356476 @default.
• W2916036130 cites W1977428833 @default.
• W2916036130 cites W1979152054 @default.
• W2916036130 cites W1988277683 @default.
• W2916036130 cites W2001466314 @default.
• W2916036130 cites W2006784317 @default.
• W2916036130 cites W2014217234 @default.
• W2916036130 cites W2030201199 @default.
• W2916036130 cites W2040389182 @default.
• W2916036130 cites W2041657876 @default.
• W2916036130 cites W2047715144 @default.
• W2916036130 cites W2059843917 @default.
• W2916036130 cites W2063158157 @default.
• W2916036130 cites W2072528935 @default.
• W2916036130 cites W2076656961 @default.
• W2916036130 cites W2077234512 @default.
• W2916036130 cites W2085750654 @default.
• W2916036130 cites W2085962068 @default.
• W2916036130 cites W2090533998 @default.
• W2916036130 cites W2092582213 @default.
• W2916036130 cites W2127751363 @default.
• W2916036130 cites W2145353453 @default.
• W2916036130 cites W2157252421 @default.
• W2916036130 cites W2162922737 @default.
• W2916036130 cites W2241580578 @default.
• W2916036130 cites W2326319228 @default.
• W2916036130 cites W2475351703 @default.
• W2916036130 cites W2801002328 @default.
• W2916036130 doi "https://doi.org/10.1016/j.bjorl.2018.12.011" @default.
• W2916036130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30852156" @default.
• W2916036130 hasPublicationYear "2020" @default.
• W2916036130 type Work @default.
• W2916036130 sameAs 2916036130 @default.
• W2916036130 citedByCount "11" @default.
• W2916036130 countsByYear W29160361302019 @default.
• W2916036130 countsByYear W29160361302020 @default.
• W2916036130 countsByYear W29160361302021 @default.
• W2916036130 countsByYear W29160361302022 @default.
• W2916036130 countsByYear W29160361302023 @default.
• W2916036130 crossrefType "journal-article" @default.
• W2916036130 hasAuthorship W2916036130A5037578201 @default.
• W2916036130 hasAuthorship W2916036130A5052413205 @default.
• W2916036130 hasAuthorship W2916036130A5060376541 @default.
• W2916036130 hasAuthorship W2916036130A5065042948 @default.
• W2916036130 hasAuthorship W2916036130A5081858972 @default.
• W2916036130 hasAuthorship W2916036130A5091064000 @default.
• W2916036130 hasBestOaLocation W29160361301 @default.
• W2916036130 hasConcept C141071460 @default.
• W2916036130 hasConcept C142724271 @default.
• W2916036130 hasConcept C146357865 @default.
• W2916036130 hasConcept C151730666 @default.
• W2916036130 hasConcept C167135981 @default.
• W2916036130 hasConcept C2776350393 @default.
• W2916036130 hasConcept C2779317333 @default.
• W2916036130 hasConcept C2780283434 @default.
• W2916036130 hasConcept C31033888 @default.
• W2916036130 hasConcept C71924100 @default.
• W2916036130 hasConcept C86803240 @default.
• W2916036130 hasConceptScore W2916036130C141071460 @default.
• W2916036130 hasConceptScore W2916036130C142724271 @default.
• W2916036130 hasConceptScore W2916036130C146357865 @default.
• W2916036130 hasConceptScore W2916036130C151730666 @default.
• W2916036130 hasConceptScore W2916036130C167135981 @default.
• W2916036130 hasConceptScore W2916036130C2776350393 @default.
• W2916036130 hasConceptScore W2916036130C2779317333 @default.
• W2916036130 hasConceptScore W2916036130C2780283434 @default.
• W2916036130 hasConceptScore W2916036130C31033888 @default.
• W2916036130 hasConceptScore W2916036130C71924100 @default.
• W2916036130 hasConceptScore W2916036130C86803240 @default.
• W2916036130 hasIssue "3" @default.
• W2916036130 hasLocation W29160361301 @default.
• W2916036130 hasLocation W29160361302 @default.
• W2916036130 hasLocation W29160361303 @default.
• W2916036130 hasOpenAccess W2916036130 @default.
• W2916036130 hasPrimaryLocation W29160361301 @default.
• W2916036130 hasRelatedWork W2010248164 @default.
• W2916036130 hasRelatedWork W2013925063 @default.
• W2916036130 hasRelatedWork W2015800912 @default.
• W2916036130 hasRelatedWork W2147588057 @default.
• W2916036130 hasRelatedWork W2373458115 @default.
• W2916036130 hasRelatedWork W2393037135 @default.
• W2916036130 hasRelatedWork W4214923111 @default.
• W2916036130 hasRelatedWork W4280561438 @default.
• W2916036130 hasRelatedWork W4295135748 @default.
• W2916036130 hasRelatedWork W4297780584 @default.
• W2916036130 hasVolume "86" @default.

• next